Unipolar Atrial Electrogram Modification Combined to the Contact Force Sensing Technology for Pulmonary Vein Isolation
Uniforce
Pulmonary Vein Isolation for the Treatment of Paroxysmal Atrial Fibrillation by Combining the Analysis of the Unipolar Atrial Electrogram Modification With the Contact Force Sensing Technology: The Uniforce Study
1 other identifier
observational
215
1 country
1
Brief Summary
Prospective observational multicentric study evaluating the efficacy of considering unipolar signal modification during radio frequency catheter ablation of patients with symptomatic paroxysmal atrial fibrillation in France between November 2013 and January 2015. All procedures were conducted according to the standard clinical care and current guidelines. Pulmonary vein isolation was guided according to force (at least 10 grams) and application vector (perpendicular to the wall) developed until the atrial unipolar electrogram recording became a complete positive signal. Patients were discharged from hospital free of any anti-arrhythmic drugs. Recurrence of arrhythmias at 12 months (primary outcome) was assessed by continuous 48-hour Holter at 1, 3, 6, 9 and 12 months post-catheter ablation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 4, 2015
CompletedFirst Posted
Study publicly available on registry
August 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedAugust 19, 2016
August 1, 2016
2.2 years
August 4, 2015
August 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence of Atrial Arrhythmias
12 months
Secondary Outcomes (1)
Frequency of Pulmonary Vein Reconnection
30 mins
Eligibility Criteria
Consecutive patients referred to the participating institutions, from November 2013 to January 2015, for catheter ablation of symptomatic and drug resistant PAF. Paroxysmal AF was considered any episode of AF that terminates spontaneously in less than seven days.
You may qualify if:
- Paroxysmal symptomatic and drug resistant atrial fibrillation (AF). Paroxysmal AF was considered any episode of AF that terminates spontaneously in less than seven days.
You may not qualify if:
- age \<18 or \>80 year-old
- left atrial volume \>200 ml
- presence of a mechanical mitral valve prosthesis
- impaired thyroid function
- left ventricular ejection fraction \<40%
- patient under guardianship
- contraindication to anticoagulant therapy
- current malignancy
- prior catheter or surgical AF ablation
- persistent or long-standing persistent AF
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital Privé Les Franciscaineslead
- Clinique St Pierre, Perpignan, Francecollaborator
- Clinique Ambroise Paré, Neuilly sur Seine, Francecollaborator
- Hôpital Privé Clairval, Marseille, Francecollaborator
- Infirmerie Protestante de Lyon, Lyon, Francecollaborator
- Centre Hospitalo-Universitaire de Brabois, Vandoeuvre Les Nancy, Francecollaborator
- Centre Hospitalier Régional Universitaire Montpelliercollaborator
- Paris Cardiovascular Research Center (Inserm U970)collaborator
- Clinique Pasteurcollaborator
Study Sites (1)
Hôpital Privé Les Franciscaines
Nîmes, 30000, France
Related Publications (3)
Bortone A, Brault-Noble G, Appetiti A, Marijon E. Elimination of the negative component of the unipolar atrial electrogram as an in vivo marker of transmural lesion creation: acute study in canines. Circ Arrhythm Electrophysiol. 2015 Aug;8(4):905-11. doi: 10.1161/CIRCEP.115.002894. Epub 2015 Jun 19.
PMID: 26092576RESULTBortone A, Appetiti A, Bouzeman A, Maupas E, Ciobotaru V, Boulenc JM, Pujadas-Berthault P, Rioux P. Unipolar signal modification as a guide for lesion creation during radiofrequency application in the left atrium: prospective study in humans in the setting of paroxysmal atrial fibrillation catheter ablation. Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1095-102. doi: 10.1161/CIRCEP.113.000749. Epub 2013 Oct 4.
PMID: 24097371RESULTBortone A, Lagrange P, Cauchemez B, Durand C, Dieuzaide P, Prevot S, Mechulan A, Pambrun T, Martin R, Parlier P, Masse A, Marijon E, Albenque JP. Elimination of the negative component of the unipolar electrogram as a local procedural endpoint during paroxysmal atrial fibrillation catheter ablation using contact-force sensing: the UNIFORCE study. J Interv Card Electrophysiol. 2017 Sep;49(3):299-306. doi: 10.1007/s10840-017-0264-4. Epub 2017 Jun 22.
PMID: 28643171DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agustin Bortone, MD
Service de Cardiologie, Hôpital Privé Les Franciscaines, Nîmes, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Head of the Clinical Electrophysiology Unit
Study Record Dates
First Submitted
August 4, 2015
First Posted
August 13, 2015
Study Start
November 1, 2013
Primary Completion
January 1, 2016
Study Completion
January 1, 2016
Last Updated
August 19, 2016
Record last verified: 2016-08